A citation-based method for searching scientific literature

Yanan Yin, Kui Che, Jianxia Hu, Hui Hua, Anbing Dong, Jueru Wang, Jiarui Yu, Qing Zhang, Shihua Zhao, Yuhang Zhao, Ping Wang, Fei Wang, Yangang Wang, Jingwei Chi, Wenhai Sun. Int J Oncol 2020
Times Cited: 3







List of co-cited articles
16 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC).
Tao Lianyuan, Xiu Dianrong, Yuan Chunhui, Ma Zhaolai, Jiang Bin. Cancer Biol Ther 2018
23
66

Genetic alterations in colorectal cancer.
Tannaz Armaghany, Jon D Wilson, Quyen Chu, Glenn Mills. Gastrointest Cancer Res 2012
248
66

Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.
Jonna Berntsson, Björn Nodin, Jakob Eberhard, Patrick Micke, Karin Jirström. Int J Cancer 2016
102
66

Transcription-coupled repair and mismatch repair contribute towards preserving genome integrity at mononucleotide repeat tracts.
Ilias Georgakopoulos-Soares, Gene Koh, Sophie E Momen, Josef Jiricny, Martin Hemberg, Serena Nik-Zainal. Nat Commun 2020
8
66

Influence of tumour micro-environment heterogeneity on therapeutic response.
Melissa R Junttila, Frederic J de Sauvage. Nature 2013
66

Genomic basis for RNA alterations in cancer.
Claudia Calabrese, Natalie R Davidson, Deniz Demircioğlu, Nuno A Fonseca, Yao He, André Kahles, Kjong-Van Lehmann, Fenglin Liu, Yuichi Shiraishi, Cameron M Soulette,[...]. Nature 2020
105
66

SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis.
Mehdi Manoochehri, Yenan Wu, Nathalia A Giese, Oliver Strobel, Stefanie Kutschmann, Florian Haller, Jörg D Hoheisel, Evgeny A Moskalev, Thilo Hackert, Andrea S Bauer. Mol Oncol 2020
7
66

MGMT Status as a Clinical Biomarker in Glioblastoma.
Madison Butler, Lorinc Pongor, Yu-Ting Su, Liqiang Xi, Mark Raffeld, Martha Quezado, Jane Trepel, Kenneth Aldape, Yves Pommier, Jing Wu. Trends Cancer 2020
28
66



EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma.
Jessamy Tiffen, Stuart J Gallagher, Fabian Filipp, Dilini Gunatilake, Abdullah Al Emran, Carleen Cullinane, Ken Dutton-Register, Lauren Aoude, Nick Hayward, Aniruddha Chatterjee,[...]. J Invest Dermatol 2020
15
66

Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.
Franz X Schaub, Varsha Dhankani, Ashton C Berger, Mihir Trivedi, Anne B Richardson, Reid Shaw, Wei Zhao, Xiaoyang Zhang, Andrea Ventura, Yuexin Liu,[...]. Cell Syst 2018
132
66

[Role and alterations of DNA methylation during the aging and cancer].
Krisztina Andrea Szigeti, Orsolya Galamb, Alexandra Kalmár, Barbara Kinga Barták, Zsófia Brigitta Nagy, Eszter Márkus, Péter Igaz, Zsolt Tulassay, Béla Molnár. Orv Hetil 2018
5
66

Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition.
Bernardo Rodriguez-Martin, Eva G Alvarez, Adrian Baez-Ortega, Jorge Zamora, Fran Supek, Jonas Demeulemeester, Martin Santamarina, Young Seok Ju, Javier Temes, Daniel Garcia-Souto,[...]. Nat Genet 2020
82
66

Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling.
Xia Shan, Chuanbao Zhang, Zheng Wang, Kuanyu Wang, Jiangfei Wang, Xiaoguang Qiu, Tao Jiang, Pei Yang. Clin Immunol 2020
7
66

Microsatellite instability in colorectal cancer.
C Richard Boland, Ajay Goel. Gastroenterology 2010
66

Effector CD4 and CD8 T cells and their role in the tumor microenvironment.
Sine Hadrup, Marco Donia, Per Thor Straten. Cancer Microenviron 2013
167
33

Comprehensive Characterization of Cancer Driver Genes and Mutations.
Matthew H Bailey, Collin Tokheim, Eduard Porta-Pardo, Sohini Sengupta, Denis Bertrand, Amila Weerasinghe, Antonio Colaprico, Michael C Wendl, Jaegil Kim, Brendan Reardon,[...]. Cell 2018
672
33

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.
Sydney R Gordon, Roy L Maute, Ben W Dulken, Gregor Hutter, Benson M George, Melissa N McCracken, Rohit Gupta, Jonathan M Tsai, Rahul Sinha, Daniel Corey,[...]. Nature 2017
756
33

The Nrf2-ARE signaling pathway: An update on its regulation and possible role in cancer prevention and treatment.
Violetta Krajka-Kuźniak, Jarosław Paluszczak, Wanda Baer-Dubowska. Pharmacol Rep 2017
26
33

NLRC5: new cancer buster?
Feng Tang, Yadi Xu, Bing Zhao. Mol Biol Rep 2020
8
33

Role of Nrf2 and Its Activators in Respiratory Diseases.
Qinmei Liu, Yun Gao, Xinxin Ci. Oxid Med Cell Longev 2019
78
33

NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs.
Mari Hämäläinen, Hanna-Riikka Teppo, Sini Skarp, Kirsi-Maria Haapasaari, Katja Porvari, Katri Vuopala, Thomas Kietzmann, Peeter Karihtala. Oxid Med Cell Longev 2019
10
33

A genome-wide DNA methylation signature for SETD1B-related syndrome.
I M Krzyzewska, S M Maas, P Henneman, K V D Lip, A Venema, K Baranano, A Chassevent, E Aref-Eshghi, A J van Essen, T Fukuda,[...]. Clin Epigenetics 2019
19
33

NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.
Joonas Haapasalo, Kristiina Nordfors, Kirsi J Granberg, Tomi Kivioja, Matti Nykter, Hannu Haapasalo, Ylermi Soini. Histol Histopathol 2018
5
33


Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Matthew Dysthe, Robin Parihar. Adv Exp Med Biol 2020
32
33

Microenvironmental regulation of tumor progression and metastasis.
Daniela F Quail, Johanna A Joyce. Nat Med 2013
33

Neutrophils in the Tumor Microenvironment.
Davalyn R Powell, Anna Huttenlocher. Trends Immunol 2016
272
33

The Keap1/Nrf2-ARE Pathway as a Pharmacological Target for Chalcones.
Matheus de Freitas Silva, Letizia Pruccoli, Fabiana Morroni, Giulia Sita, Francesca Seghetti, Claudio Viegas, Andrea Tarozzi. Molecules 2018
38
33



The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance.
A L Furfaro, N Traverso, C Domenicotti, S Piras, L Moretta, U M Marinari, M A Pronzato, M Nitti. Oxid Med Cell Longev 2016
148
33

Immune checkpoint blockade: a common denominator approach to cancer therapy.
Suzanne L Topalian, Charles G Drake, Drew M Pardoll. Cancer Cell 2015
33

Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation.
Erin M Bekes, Bernhard Schweighofer, Tatyana A Kupriyanova, Ewa Zajac, Veronica C Ardi, James P Quigley, Elena I Deryugina. Am J Pathol 2011
182
33

Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2.
Lingmin Zhang, Ning Wang, Suna Zhou, Wenguang Ye, Guixia Jing, Mingxin Zhang. J Exp Clin Cancer Res 2012
60
33

Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.
Shaohua Ma, Chorlada Paiboonrungruan, Tiansheng Yan, Kevin P Williams, M Ben Major, Xiaoxin Luke Chen. Ann N Y Acad Sci 2018
18
33

Functional Role of NRF2 in Cervical Carcinogenesis.
Jun-Qi Ma, Hatila Tuersun, Shu-Juan Jiao, Jian-He Zheng, Jing-Bao Xiao, Ayshamgul Hasim. PLoS One 2015
28
33

Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?
Luisa Chocarro de Erauso, Miren Zuazo, Hugo Arasanz, Ana Bocanegra, Carlos Hernandez, Gonzalo Fernandez, Maria Jesus Garcia-Granda, Ester Blanco, Ruth Vera, Grazyna Kochan,[...]. Front Pharmacol 2020
17
33

Procyanidins from Cinnamomi Cortex promote proteasome-independent degradation of nuclear Nrf2 through phosphorylation of insulin-like growth factor-1 receptor in A549 cells.
Tomokazu Ohnuma, Kazuya Sakamoto, Asumi Shinoda, Chiaki Takagi, Shoko Ohno, Takahito Nishiyama, Kenichiro Ogura, Akira Hiratsuka. Arch Biochem Biophys 2017
7
33


Nrf2: friend or foe for chemoprevention?
Thomas W Kensler, Nobunao Wakabayashi. Carcinogenesis 2010
331
33

Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming.
Yoichiro Mitsuishi, Keiko Taguchi, Yukie Kawatani, Tatsuhiro Shibata, Toshihiro Nukiwa, Hiroyuki Aburatani, Masayuki Yamamoto, Hozumi Motohashi. Cancer Cell 2012
771
33

The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes.
L Bonanno, A Pavan, M V Dieci, E Di Liso, M Schiavon, G Comacchio, I Attili, G Pasello, F Calabrese, F Rea,[...]. Eur J Cancer 2018
42
33

Molecular pathology of Lynch syndrome.
Guia Cerretelli, Ann Ager, Mark J Arends, Ian M Frayling. J Pathol 2020
24
33

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.
Padmanee Sharma, Siwen Hu-Lieskovan, Jennifer A Wargo, Antoni Ribas. Cell 2017
33


Microenvironmental regulation of tumour angiogenesis.
Michele De Palma, Daniela Biziato, Tatiana V Petrova. Nat Rev Cancer 2017
680
33


Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical Carcinogenesis.
Georgia Kontostathi, Jerome Zoidakis, Manousos Makridakis, Vasiliki Lygirou, George Mermelekas, Theofilos Papadopoulos, Konstantinos Vougas, Alexios Vlamis-Gardikas, Peter Drakakis, Dimitrios Loutradis,[...]. Biomed Res Int 2017
25
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.